6 Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus – the met-remodel trial

Mohapradeep Mohan; Shaween Al-Talabany; Angela McKinnie; Ify Mordi; Jagdeep Singh; Stephen Gandy; Fatima Baig; Muhammed Hussain; U Bhalraam; Faisel Khan; Anna Maria Choy; Graheme Houston; Jacob George; Allan Struthers; Chim Lang

doi:10.1136/heartjnl-2018-BCS.6

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Browse by collection

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Acute Coronary Syndromes

6 Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus – the met-remodel trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Mohan M, Al-Talabany S, McKinnie A, et al

6 Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus – the met-remodel trial

Heart 2018;104:A6.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password